Tricare East Guideline - Overactive Bladder & Urinary Incontinence
Tricare East POC Policy Set · effective 2026-01-01 · version v1
Metadata
Doc IDguideline::tricare::oab_incontinence_v1
PayerTricare East
Payer Slugtricare
Topicoab incontinence
Document Typepayer_guideline
Chunks5
Covered ICD Codes (9)
N32.81
N39.3
N39.41
R33.9
R35.0
R35.1
R39.9
R39.15
N81.6
Procedure Keywords (8)
urodynamic testing
InterStim sacral neuromodulation
Botox bladder injection
percutaneous tibial nerve stimulation (PTNS)
anticholinergic therapy
beta-3 agonist therapy
midurethral sling
bladder retraining
Guideline Chunks (5)
Each chunk has its own embedding and is independently retrievable
guideline::tricare::oab_incontinence_v1#chunk0
Diagnostic urodynamic testing and advanced therapeutic interventions for overactive bladder (OAB), urinary incontinence, and related lower urinary tract symptoms may be considered when conservative therapy has failed.
guideline::tricare::oab_incontinence_v1#chunk1
1. Overactive bladder (ICD N32.81) with documented symptoms refractory to first-line therapy.
2. Stress incontinence (ICD N39.3) impacting daily function.
3. Urge incontinence (ICD N39.41) with documented frequency and severity.
4. Urinary retention (ICD R33.9) requiring evaluation or intervention.
5. Frequent urination (ICD R35.0), nocturia (ICD R35.1), or urgency (ICD R39.15).
6. Lower urinary tract symptoms (ICD R39.9) of unclear etiology.
7. Pelvic organ prolapse including rectocele (ICD N81.6) contributing to symptoms.
guideline::tricare::oab_incontinence_v1#chunk2
1. Symptom diary or validated symptom score (OABSS, ICIQ).
2. Trial and failure of behavioral therapy and at least one anticholinergic or beta-3 agonist.
3. Post-void residual measurement.
4. Urinalysis to exclude infection.
5. Functional impact documentation (employment, sleep, social).
6. Pelvic examination findings for incontinence cases.
guideline::tricare::oab_incontinence_v1#chunk3
1. No documented trial of conservative or pharmacologic therapy.
2. Missing urinalysis to rule out infection-mediated symptoms.
3. Symptom severity below intervention threshold.
4. Requested device therapy without trial of less invasive options.
guideline::tricare::oab_incontinence_v1#chunk4
Likely eligible when validated symptom score documents moderate-to-severe symptoms, conservative and pharmacologic therapy have been trialed and failed, and infection has been excluded.
Manual review when therapy trial is incomplete or symptom severity is mild-to-moderate.
Likely not eligible when no behavioral or pharmacologic therapy has been attempted or when symptoms are below clinical intervention threshold.